{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:48:33Z","timestamp":1787003313351,"version":"build-2736575974"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00347728"],"award-info":[{"award-number":["RS-2024-00347728"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002641","name":"Konkuk University","doi-asserted-by":"publisher","award":["Konkuk University\u2019s research support program for its faculty on sabbatical leave in 2024"],"award-info":[{"award-number":["Konkuk University\u2019s research support program for its faculty on sabbatical leave in 2024"]}],"id":[{"id":"10.13039\/501100002641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-026-00647-w","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:45:59Z","timestamp":1768589159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Asthma-mediated control of optic glioma growth via T cell-microglia interactions: A mathematical model"],"prefix":"10.1038","volume":"12","author":[{"given":"Donggu","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"647_CR1","first-page":"170004","volume":"3","author":"D Gutmann","year":"2017","unstructured":"Gutmann, D. et al. Neurofibromatosis type 1. Nat. Rev. Dis. Prim. 3, 170004 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"647_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick, R., Ferner, R., Liu, G. & Gutmann, D. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann. Neurol. 61, 189\u2013198 (2007).","journal-title":"Ann. Neurol."},{"key":"647_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","volume":"135","author":"F Yang","year":"2008","unstructured":"Yang, F. et al. Nf1-dependent tumors require a microenvironment containing nf1+\/\u2013 and c-kit-dependent bone marrow. Cell 135, 437\u2013448 (2008).","journal-title":"Cell"},{"key":"647_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-012-1056-7","volume":"125","author":"C Prada","year":"2013","unstructured":"Prada, C. et al. Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition. Acta Neuropathol. 125, 159\u2013168 (2013).","journal-title":"Acta Neuropathol."},{"key":"647_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","volume":"104","author":"K Cichowski","year":"2001","unstructured":"Cichowski, K. & Jacks, T. Nf1 tumor suppressor gene function: narrowing the gap. Cell 104, 593\u2013604 (2001).","journal-title":"Cell"},{"key":"647_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.stemcr.2020.03.007","volume":"14","author":"C Anastasaki","year":"2020","unstructured":"Anastasaki, C. et al. Human iPSC-derived neurons and cerebral organoids establish differential effects of germline NF1 gene mutations. Stem Cell Rep. 14, 541\u2013550 (2020).","journal-title":"Stem Cell Rep."},{"key":"647_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30466-6","volume":"13","author":"C Anastasaki","year":"2022","unstructured":"Anastasaki, C. et al. Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. Nat. Commun. 13, 2785 (2022).","journal-title":"Nat. Commun."},{"key":"647_CR8","doi-asserted-by":"publisher","first-page":"049362","DOI":"10.1242\/dmm.049362","volume":"15","author":"C Anastasaki","year":"2022","unstructured":"Anastasaki, C., Orozco, P. & Gutmann, D. Ras and beyond: the many faces of the neurofibromatosis type 1 protein. Dis. Models Mech. 15, 049362 (2022).","journal-title":"Dis. Models Mech."},{"key":"647_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15770-3","volume":"11","author":"X Guo","year":"2020","unstructured":"Guo, X. et al. Midkine activation of CD8+ T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth. Nat. Commun. 11, 2177 (2020).","journal-title":"Nat. Commun."},{"key":"647_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1083\/jcb.110.3.607","volume":"110","author":"K Kadomatsu","year":"1990","unstructured":"Kadomatsu, K., Huang, R., Suganuma, T., Murata, F. & Muramatsu, T. A retinoic acid responsive gene mk found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J. Cell Biol. 110, 607\u2013616 (1990).","journal-title":"J. Cell Biol."},{"key":"647_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/oxfordjournals.jbchem.a003231","volume":"132","author":"T Muramatsu","year":"2002","unstructured":"Muramatsu, T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J. Biochem. 132, 359\u2013371 (2002).","journal-title":"J. Biochem."},{"key":"647_CR12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/neuonc\/noz080","volume":"21","author":"X Guo","year":"2019","unstructured":"Guo, X., Pan, Y. & Gutmann, D. Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia. Neuro Oncol. 21, 1250\u20131262 (2019).","journal-title":"Neuro Oncol."},{"key":"647_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gad.310797.117","volume":"32","author":"Y Pan","year":"2018","unstructured":"Pan, Y. et al. Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of NF1 low-grade glioma growth. Genes Dev. 32, 491\u2013496 (2018).","journal-title":"Genes Dev."},{"key":"647_CR14","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.3892\/or.2016.5171","volume":"36","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Hypoxia and macrophages promote glioblastoma invasion by the CCL4\u2013CCR5 axis. Oncol. Rep. 36, 3522\u20133528 (2016).","journal-title":"Oncol. Rep."},{"key":"647_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2174\/18715273113126660173","volume":"12","author":"J Louboutin","year":"2013","unstructured":"Louboutin, J. & Strayer, D. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy. CNS Neurol. Disord. Drug Targets 12, 815\u2013829 (2013).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"647_CR16","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.neuron.2023.04.006","volume":"111","author":"B Festa","year":"2023","unstructured":"Festa, B. et al. Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration. Neuron 111, 2021\u20132037 (2023).","journal-title":"Neuron"},{"key":"647_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2478\/raon-2019-0057","volume":"53","author":"M Kranjc","year":"2019","unstructured":"Kranjc, M., Novak, M., Pestell, R. & Lah, T. Cytokine ccl5 and receptor CCR5 axis in glioblastoma multiforme. Radio. Oncol. 53, 397\u2013406 (2019).","journal-title":"Radio. Oncol."},{"key":"647_CR18","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.3390\/ijms21207619","volume":"21","author":"J Korbecki","year":"2020","unstructured":"Korbecki, J., Grochans, S., Gutowska, I., Barczak, K. & Baranowska-Bosiacka, I. CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands. Int. J. Mol. Sci. 21, 7619 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"647_CR19","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.3390\/biomedicines11112910","volume":"11","author":"N Kim","year":"2023","unstructured":"Kim, N. et al. CCR8 as a therapeutic novel target: omics-integrated comprehensive analysis for systematically prioritizing indications. Biomedicines 11, 2910 (2023).","journal-title":"Biomedicines"},{"key":"647_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.7150\/ijbs.26703","volume":"15","author":"A Jorda","year":"2019","unstructured":"Jorda, A. et al. Changes in chemokines and chemokine receptors expression in a mouse model of Alzheimer\u2019s disease. Int. J. Biol. Sci. 15, 453\u2013463 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"647_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27455-6","volume":"12","author":"J Chatterjee","year":"2021","unstructured":"Chatterjee, J. et al. Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia. Nat. Commun. 12, 7122 (2021).","journal-title":"Nat. Commun."},{"key":"647_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40478-024-01735-w","volume":"12","author":"J Chatterjee","year":"2024","unstructured":"Chatterjee, J. et al. Brain injury drives optic glioma formation through neuron-glia signaling. Acta Neuropathol. Commun. 12, 21 (2024).","journal-title":"Acta Neuropathol. Commun."},{"key":"647_CR23","doi-asserted-by":"publisher","first-page":"10337","DOI":"10.3390\/ijms241210337","volume":"24","author":"P Shi","year":"2023","unstructured":"Shi, P., Xu, J. & Cui, H. The recent research progress of NF-\u03baB signaling on the proliferation, migration, invasion, immune escape and drug resistance of glioblastoma. Int. J. Mol. Sci. 24, 10337 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"647_CR24","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3390\/ijms19051477","volume":"19","author":"D Aldinucci","year":"2018","unstructured":"Aldinucci, D. & Casagrande, N. Inhibition of the CCL5\/CCR5 axis against the progression of gastric cancer. Int. J. Mol. Sci. 19, 1477 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"647_CR25","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3390\/cancers12071765","volume":"12","author":"D Aldinucci","year":"2020","unstructured":"Aldinucci, D., Borghese, C. & Casagrande, N. The ccl5\/ccr5 axis in cancer progression. Cancers (Basel) 12, 1765 (2020).","journal-title":"Cancers (Basel)"},{"key":"647_CR26","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/nri2870","volume":"10","author":"C Lloyd","year":"2010","unstructured":"Lloyd, C. & Hessel, E. Functions of T cells in asthma: more than just T(h)2 cells. Nat. Rev. Immunol. 10, 838\u2013848 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"647_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","volume":"42","author":"R Iozzo","year":"2015","unstructured":"Iozzo, R. & Schaefer, L. Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol. 42, 11\u201355 (2015).","journal-title":"Matrix Biol."},{"key":"647_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/gt.2009.142","volume":"17","author":"I Choi","year":"2010","unstructured":"Choi, I. et al. Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy. Gene Ther. 17, 190\u2013201 (2010).","journal-title":"Gene Ther."},{"key":"647_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJM199802123380706","volume":"338","author":"A Luster","year":"1998","unstructured":"Luster, A. Chemokines\u2013chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338, 436\u2013445 (1998).","journal-title":"N. Engl. J. Med."},{"key":"647_CR30","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bcp.2008.11.014","volume":"77","author":"C Huang","year":"2009","unstructured":"Huang, C. et al. Ccl5 increases lung cancer migration via pi3k, akt and nf-kappab pathways. Biochem. Pharm. 77, 794\u2013803 (2009).","journal-title":"Biochem. Pharm."},{"key":"647_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41420-018-0063-4","volume":"4","author":"Z Cui","year":"2018","unstructured":"Cui, Z. et al. Cordycepin induces apoptosis of human ovarian cancer cells by inhibiting ccl5-mediated akt\/nf-\u03bab signaling pathway. Cell Death Discov. 4, 62 (2018).","journal-title":"Cell Death Discov."},{"key":"647_CR32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin, M. & Greten, F. Nf-kappab: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749\u2013759 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"647_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/346281a0","volume":"346","author":"Y Yamaguchi","year":"1990","unstructured":"Yamaguchi, Y., Mann, D. & Ruoslahti, E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346, 281\u2013284 (1990).","journal-title":"Nature"},{"key":"647_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"D Quail","year":"2017","unstructured":"Quail, D. & Joyce, J. The microenvironmental landscape of brain tumors. Cancer Cell 31, 326\u2013341 (2017).","journal-title":"Cancer Cell"},{"key":"647_CR35","doi-asserted-by":"publisher","first-page":"1310094","DOI":"10.3389\/fimmu.2023.1310094","volume":"14","author":"E Neumaier","year":"2023","unstructured":"Neumaier, E., Rothhammer, V. & Linnerbauer, M. The role of midkine in health and disease. Front. Immunol. 14, 1310094 (2023).","journal-title":"Front. Immunol."},{"key":"647_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","volume":"254","author":"S Marino","year":"2008","unstructured":"Marino, S., Hogue, I., Ray, C. & Kirschner, D. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J. Theor. Biol. 254, 178\u201396 (2008).","journal-title":"J. Theor. Biol."},{"key":"647_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0021-9991(76)90041-3","volume":"22","author":"D Gillespie","year":"1976","unstructured":"Gillespie, D. A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. J. Comput. Phys. 22, 403\u2013434 (1976).","journal-title":"J. Comput. Phys."},{"key":"647_CR38","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1021\/j100540a008","volume":"81","author":"D Gillespie","year":"1977","unstructured":"Gillespie, D. Exact stochastic simulation of coupled chemical reactions. J. Phys. Chem. 81, 2340\u20132361 (1977).","journal-title":"J. Phys. Chem."},{"key":"647_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev.physchem.58.032806.104637","volume":"58","author":"D Gillespie","year":"2007","unstructured":"Gillespie, D. Stochastic simulation of chemical kinetics. Annu. Rev. Phys. Chem. 58, 35\u201355 (2007).","journal-title":"Annu. Rev. Phys. Chem."},{"key":"647_CR40","unstructured":"Okun, L. Particle Physics: the Quest for the Substance of Substance (Contemporary Concepts in Physics) 1st edn (CRC Press, 1985)."},{"key":"647_CR41","doi-asserted-by":"publisher","first-page":"030801","DOI":"10.1103\/PhysRevLett.106.030801","volume":"106","author":"B Andreas","year":"2011","unstructured":"Andreas, B. et al. Determination of the Avogadro constant by counting the atoms in a 28Si crystal. Phys. Rev. Lett. 106, 030801 (2011).","journal-title":"Phys. Rev. Lett."},{"key":"647_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/2211-5463.12076","volume":"6","author":"T Yao","year":"2016","unstructured":"Yao, T. et al. Decorin-mediated inhibition of the migration of u87mg glioma cells involves activation of autophagy and suppression of tgf-\u03b2 signaling. FEBS Open Bio 6, 707\u2013719 (2016).","journal-title":"FEBS Open Bio"},{"key":"647_CR43","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa2210233","volume":"387","author":"M Rohaan","year":"2022","unstructured":"Rohaan, M. et al. Tumor-infiltrating lymphocyte therapy or ipilimumab in advanced melanoma. N. Engl. J. Med. 387, 2113\u20132125 (2022).","journal-title":"N. Engl. J. Med."},{"key":"647_CR44","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1158\/1078-0432.CCR-22-1922","volume":"29","author":"A Warner","year":"2023","unstructured":"Warner, A., Corrie, P. & Hamid, O. Tumor-infiltrating lymphocyte therapy in melanoma: facts to the future. Clin. Cancer Res. 29, 1835\u20131854 (2023).","journal-title":"Clin. Cancer Res."},{"key":"647_CR45","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1158\/1078-0432.CCR-10-2272","volume":"17","author":"J Weber","year":"2011","unstructured":"Weber, J. et al. White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the ctep subcommittee on adoptive cell therapy. Clin. Cancer Res. 17, 1664\u20131673 (2011).","journal-title":"Clin. Cancer Res."},{"key":"647_CR46","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.3489291","volume":"233","author":"S Rosenberg","year":"1986","unstructured":"Rosenberg, S., Spiess, P. & Lafreniere, R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233, 1318\u20131321 (1986).","journal-title":"Science"},{"key":"647_CR47","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.4049\/jimmunol.132.5.2259","volume":"132","author":"M Cheever","year":"1984","unstructured":"Cheever, M. et al. Interleukin 2 administered in vivo induces the growth of cultured t cells in vivo. J. Immunol. 132, 2259\u20132265 (1984).","journal-title":"J. Immunol."},{"key":"647_CR48","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/j.1600-6143.2012.04133.x","volume":"12","author":"A Aoyama","year":"2012","unstructured":"Aoyama, A. et al. Low-dose il-2 for in vivo expansion of cd4+ and cd8+ regulatory t cells in nonhuman primates. Am. J. Transpl. 12, 2532\u20132537 (2012).","journal-title":"Am. J. Transpl."},{"key":"647_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11782-w","volume":"10","author":"Z Sun","year":"2019","unstructured":"Sun, Z. et al. A next-generation tumor-targeting il-2 preferentially promotes tumor-infiltrating cd8+ t-cell response and effective tumor control. Nat. Commun. 10, 3874 (2019).","journal-title":"Nat. Commun."},{"key":"647_CR50","first-page":"617","volume":"23","author":"F Roncarolo","year":"2012","unstructured":"Roncarolo, F. & Infante-Rivard, C. Asthma and risk of brain cancer in children. Cancer Causes Control 23, 617\u2013623 (2012).","journal-title":"Cancer Causes Control"},{"key":"647_CR51","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1158\/0008-5472.CAN-04-3728","volume":"65","author":"J Schwartzbaum","year":"2005","unstructured":"Schwartzbaum, J. et al. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res. 65, 6459\u20136465 (2005).","journal-title":"Cancer Res."},{"key":"647_CR52","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ijc.10239","volume":"98","author":"J Wiemels","year":"2002","unstructured":"Wiemels, J. et al. History of allergies among adults with glioma and controls. Int. J. Cancer 98, 609\u2013615 (2002).","journal-title":"Int. J. Cancer"},{"key":"647_CR53","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/jnci\/djm170","volume":"99","author":"E Linos","year":"2007","unstructured":"Linos, E., Raine, T., Alonso, A. & Michaud, D. Atopy and risk of brain tumors: a meta-analysis. J. Natl. Cancer Inst. 99, 1544\u20131550 (2007).","journal-title":"J. Natl. Cancer Inst."},{"key":"647_CR54","first-page":"1665","volume":"23","author":"C Infante-Rivard","year":"2012","unstructured":"Infante-Rivard, C., Roncarolo, F. & Doucette, K. Reliability of cancer family history reported by parents in a case-control study of childhood leukemia. Cancer Causes Control 23, 1665\u20131672 (2012).","journal-title":"Cancer Causes Control"},{"key":"647_CR55","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/aje\/kwm203","volume":"166","author":"A Wigertz","year":"2007","unstructured":"Wigertz, A. et al. Allergic conditions and brain tumor risk. Am. J. Epidemiol. 166, 941\u2013950 (2007).","journal-title":"Am. J. Epidemiol."},{"key":"647_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2007.10.007","volume":"44","author":"N Harding","year":"2008","unstructured":"Harding, N., Birch, J., Hepworth, S. & McKinney, P. Atopic dysfunction and risk of central nervous system tumours in children. Eur. J. Cancer 44, 92\u201399 (2008).","journal-title":"Eur. J. Cancer"},{"key":"647_CR57","first-page":"949","volume":"24","author":"M Turner","year":"2013","unstructured":"Turner, M. et al. Allergy and brain tumors in the interphone study: pooled results from Australia, Canada, France, Israel, and New Zealand. Cancer Causes Control 24, 949\u2013960 (2013).","journal-title":"Cancer Causes Control"},{"key":"647_CR58","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10689-015-9855-3","volume":"15","author":"B Porcelli","year":"2016","unstructured":"Porcelli, B., Zoellner, N., Abadin, S., Gutmann, D. & Johnson, K. Associations between allergic conditions and pediatric brain tumors in neurofibromatosis type 1. Fam. Cancer 15, 301\u2013308 (2016).","journal-title":"Fam. Cancer"},{"key":"647_CR59","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.celrep.2015.02.041","volume":"10","author":"Y Chen","year":"2015","unstructured":"Chen, Y. et al. Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. Cell Rep. 10, 1899\u20131912 (2015).","journal-title":"Cell Rep."},{"key":"647_CR60","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.neo.2015.10.002","volume":"17","author":"A Solga","year":"2015","unstructured":"Solga, A. et al. RNA sequencing of tumor-associated microglia reveals ccl5 as a stromal chemokine critical for neurofibromatosis-1 glioma growth. Neoplasia 17, 776\u2013788 (2015).","journal-title":"Neoplasia"},{"key":"647_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12865-021-00435-7","volume":"22","author":"S Ghaffari","year":"2021","unstructured":"Ghaffari, S. et al. Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of t-cell expansion for adoptive immunotherapy. BMC Immunol. 22, 43 (2021).","journal-title":"BMC Immunol."},{"key":"647_CR62","doi-asserted-by":"publisher","first-page":"113229","DOI":"10.1016\/j.jim.2022.113229","volume":"503","author":"T Kongkaew","year":"2022","unstructured":"Kongkaew, T. et al. Til expansion with high dose il-2 or low dose il-2 with anti-cd3\/anti-cd28 stimulation provides different quality of til-expanded t cell clones. J. Immunol. Methods 503, 113229 (2022).","journal-title":"J. Immunol. Methods"},{"key":"647_CR63","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.2337\/dc08-1034","volume":"31","author":"J Mitri","year":"2008","unstructured":"Mitri, J., Castillo, J. & Pittas, A. Diabetes and risk of non-Hodgkin\u2019s lymphoma: a meta-analysis of observational studies. Diab. Care 31, 2391\u20132397 (2008).","journal-title":"Diab. Care"},{"key":"647_CR64","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ijc.22717","volume":"121","author":"S Larsson","year":"2007","unstructured":"Larsson, S., Mantzoros, C. & Wolk, A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int. J. Cancer 121, 856\u2013862 (2007).","journal-title":"Int. J. Cancer"},{"key":"647_CR65","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","volume":"92","author":"R Huxley","year":"2005","unstructured":"Huxley, R., Ansary-Moghaddam, A., de Gonzalez, A., Barzi, F. & Woodward, M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br. J. Cancer 92, 2076\u20132083 (2005).","journal-title":"Br. J. Cancer"},{"key":"647_CR66","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","volume":"50","author":"E Friberg","year":"2007","unstructured":"Friberg, E., Orsini, N., Mantzoros, C. & Wolk, A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50, 1365\u20131374 (2007).","journal-title":"Diabetologia"},{"key":"647_CR67","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","volume":"4","author":"H El-Serag","year":"2006","unstructured":"El-Serag, H., Hampel, H. & Javadi, F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin. Gastroenterol. Hepatol. 4, 369\u2013380 (2006).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"647_CR68","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1001\/jama.2008.824","volume":"300","author":"B Barone","year":"2008","unstructured":"Barone, B. et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300, 2754\u20132764 (2008).","journal-title":"JAMA"},{"key":"647_CR69","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.18632\/oncotarget.6605","volume":"7","author":"L Zhao","year":"2016","unstructured":"Zhao, L., Zheng, Z. & Huang, P. Diabetes mellitus and the risk of glioma: a meta-analysis. Oncotarget 7, 4483\u20134489 (2016).","journal-title":"Oncotarget"},{"key":"647_CR70","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/neuonc\/nov100","volume":"18","author":"C Seliger","year":"2016","unstructured":"Seliger, C. et al. Diabetes, use of antidiabetic drugs, and the risk of glioma. Neuro Oncol. 18, 340\u2013349 (2016).","journal-title":"Neuro Oncol."},{"key":"647_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01553-2","volume":"7","author":"J Schwartzbaum","year":"2017","unstructured":"Schwartzbaum, J. et al. Associations between prediagnostic blood glucose levels, diabetes, and glioma. Sci. Rep. 7, 1436 (2017).","journal-title":"Sci. Rep."},{"key":"647_CR72","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1158\/1055-9965.EPI-13-0913","volume":"23","author":"C Kitahara","year":"2014","unstructured":"Kitahara, C. et al. Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studies. Cancer Epidemiol. Biomark. Prev. 23, 47\u201354 (2014).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"647_CR73","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1158\/1078-0432.CCR-19-2520","volume":"26","author":"I Zhang","year":"2020","unstructured":"Zhang, I. et al. Local and systemic immune dysregulation alters glioma growth in hyperglycemic mice. Clin. Cancer Res. 26, 2740\u20132753 (2020).","journal-title":"Clin. Cancer Res."},{"key":"647_CR74","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40035-025-00507-3","volume":"14","author":"Y Lin","year":"2025","unstructured":"Lin, Y. et al. Disease-disease interactions: molecular links of neurodegenerative diseases with cancer, viral infections, and type 2 diabetes. Transl. Neurodegener. 14, 52 (2025).","journal-title":"Transl. Neurodegener."},{"key":"647_CR75","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1212\/WNL.0b013e31829c5ec1","volume":"81","author":"M Musicco","year":"2013","unstructured":"Musicco, M. et al. Inverse occurrence of cancer and alzheimer disease: a population-based incidence study. Neurology 81, 322\u2013328 (2013).","journal-title":"Neurology"},{"key":"647_CR76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000341411","volume":"40","author":"S Ou","year":"2013","unstructured":"Ou, S. et al. Does alzheimer\u2019s disease protect against cancers? A nationwide population-based study. Neuroepidemiology 40, 42\u201349 (2013).","journal-title":"Neuroepidemiology"},{"key":"647_CR77","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1038\/s41388-019-1124-8","volume":"39","author":"P Filippou","year":"2020","unstructured":"Filippou, P., Karagiannis, G. & Constantinidou, A. Midkine (mdk) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene 39, 2040\u20132054 (2020).","journal-title":"Oncogene"},{"key":"647_CR78","doi-asserted-by":"publisher","first-page":"8739","DOI":"10.3390\/ijms24108739","volume":"24","author":"M Saikia","year":"2023","unstructured":"Saikia, M., Cheung, N., Singh, A. & Kapoor, V. Role of midkine in cancer drug resistance: regulators of its expression and its molecular targeting. Int. J. Mol. Sci. 24, 8739 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"647_CR79","doi-asserted-by":"publisher","first-page":"12699","DOI":"10.1074\/jbc.M112.419366","volume":"288","author":"C Bocian","year":"2013","unstructured":"Bocian, C. et al. Decorin potentiates interferon-\u03b3 activity in a model of allergic inflammation. J. Biol. Chem. 288, 12699\u201312711 (2013).","journal-title":"J. Biol. Chem."},{"key":"647_CR80","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.4049\/jimmunol.170.9.4450","volume":"170","author":"M Comalada","year":"2003","unstructured":"Comalada, M. et al. Decorin reverses the repressive effect of autocrine-produced tgf-beta on mouse macrophage activation. J. Immunol. 170, 4450\u20134456 (2003).","journal-title":"J. Immunol."},{"key":"647_CR81","doi-asserted-by":"publisher","first-page":"844","DOI":"10.2353\/ajpath.2008.080275","volume":"173","author":"S Goldoni","year":"2008","unstructured":"Goldoni, S. et al. An antimetastatic role for decorin in breast cancer. Am. J. Pathol. 173, 844\u2013855 (2008).","journal-title":"Am. J. Pathol."},{"key":"647_CR82","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/sj.onc.1208329","volume":"24","author":"C Reed","year":"2005","unstructured":"Reed, C. et al. Decorin prevents metastatic spreading of breast cancer. Oncogene 24, 1104\u20131110 (2005).","journal-title":"Oncogene"},{"key":"647_CR83","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1038\/sj.onc.1205595","volume":"21","author":"D Grant","year":"2002","unstructured":"Grant, D. et al. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 21, 4765\u20134777 (2002).","journal-title":"Oncogene"},{"key":"647_CR84","doi-asserted-by":"publisher","first-page":"26408","DOI":"10.1074\/jbc.M602853200","volume":"281","author":"D Seidler","year":"2006","unstructured":"Seidler, D. et al. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J. Biol. Chem. 281, 26408\u201326418 (2006).","journal-title":"J. Biol. Chem."},{"key":"647_CR85","doi-asserted-by":"publisher","first-page":"34712","DOI":"10.1074\/jbc.M111.262766","volume":"286","author":"R Iozzo","year":"2011","unstructured":"Iozzo, R. et al. Decorin antagonizes igf receptor i (igf-ir) function by interfering with igf-ir activity and attenuating downstream signaling. J. Biol. Chem. 286, 34712\u201334721 (2011).","journal-title":"J. Biol. Chem."},{"key":"647_CR86","doi-asserted-by":"publisher","first-page":"42075","DOI":"10.1074\/jbc.M110.172841","volume":"285","author":"S Buraschi","year":"2010","unstructured":"Buraschi, S. et al. Decorin antagonizes met receptor activity and down-regulates \u03b2-catenin and myc levels. J. Biol. Chem. 285, 42075\u201342085 (2010).","journal-title":"J. Biol. Chem."},{"key":"647_CR87","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1152\/ajplung.00300.2009","volume":"300","author":"C Marchica","year":"2011","unstructured":"Marchica, C. et al. A role for decorin in a murine model of allergen-induced asthma. Am. J. Physiol. Lung Cell Mol. Physiol. 300, 863\u2013873 (2011).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"647_CR88","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1142\/S0218202507002479","volume":"17","author":"Y Kim","year":"2007","unstructured":"Kim, Y., Stolarska, M. & Othmer, H. A hybrid model for tumor spheroid growth in vitro I: theoretical development and early results. Math. Models Methods Appl. Sci. 17, 1773\u20131798 (2007).","journal-title":"Math. Models Methods Appl. Sci."},{"key":"647_CR89","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.3934\/mbe.2024173","volume":"21","author":"D Lee","year":"2024","unstructured":"Lee, D., V, A. A. D. L. R. & Kim, Y. Optimal strategies of oncolytic virus-bortezomib therapy via the apoptotic, necroptotic, and oncolysis signaling network. Math. Biosci. Eng. 21, 3876\u20133909 (2024).","journal-title":"Math. Biosci. Eng."},{"key":"647_CR90","doi-asserted-by":"publisher","first-page":"20190390","DOI":"10.1098\/rstb.2019.0390","volume":"375","author":"Y Kim","year":"2020","unstructured":"Kim, Y., Lee, D. & Lawler, S. Collective invasion of glioma cells through OCT1 signalling and interaction with reactive astrocytes after surgery. Philos. Trans. R. Soc. B 375, 20190390 (2020).","journal-title":"Philos. Trans. R. Soc. B"},{"key":"647_CR91","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/cancers11020215","volume":"11","author":"Y Kim","year":"2019","unstructured":"Kim, Y., Lee, J., Lee, D. & Othmer, H. Synergistic effects of bortezomib-OV therapy and anti-invasive strategies in glioblastoma: a mathematical model. Cancers 11, 215 (2019).","journal-title":"Cancers"},{"key":"647_CR92","doi-asserted-by":"publisher","first-page":"e0204865","DOI":"10.1371\/journal.pone.0204865","volume":"13","author":"Y Kim","year":"2018","unstructured":"Kim, Y. et al. Role of extracellular matrix and microenvironment in regulation of tumor growth and lar-mediated invasion in glioblastoma. PLoS ONE 13, e0204865 (2018).","journal-title":"PLoS ONE"},{"key":"647_CR93","doi-asserted-by":"publisher","first-page":"e0114370","DOI":"10.1371\/journal.pone.0114370","volume":"10","author":"Y Kim","year":"2015","unstructured":"Kim, Y. et al. Strategies of eradicating glioma cells: a multi-scale mathematical model with miR-451-AMPK-mTOR control. PLoS ONE 10, e0114370 (2015).","journal-title":"PLoS ONE"},{"key":"647_CR94","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3934\/mbe.2015.12.1141","volume":"12","author":"Y Kim","year":"2015","unstructured":"Kim, Y. & Othmer, H. Hybrid models of cell and tissue dynamics in tumor growth. Math. Bios Eng. 12, 1141\u20131156 (2015).","journal-title":"Math. Bios Eng."},{"key":"647_CR95","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s11538-012-9787-0","volume":"75","author":"Y Kim","year":"2013","unstructured":"Kim, Y. & Othmer, H. A hybrid model of tumor\u2013stromal interactions in breast cancer. Bull. Math. Biol. 75, 1304\u20131350 (2013).","journal-title":"Bull. Math. Biol."},{"key":"647_CR96","first-page":"969","volume":"18","author":"Y Kim","year":"2013","unstructured":"Kim, Y. & Roh, S. A hybrid model for cell proliferation and migration in glioblastoma. Discret. Contin. Dyn. Syst.-B 18, 969\u20131015 (2013).","journal-title":"Discret. Contin. Dyn. Syst.-B"},{"key":"647_CR97","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2013.00053","volume":"3","author":"Y Kim","year":"2013","unstructured":"Kim, Y. Regulation of cell proliferation and migration in glioblastoma: new therapeutic approach. Front. Oncol. 3, 53 (2013).","journal-title":"Front. Oncol."},{"key":"647_CR98","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pbiomolbio.2011.06.006","volume":"106","author":"Y Kim","year":"2011","unstructured":"Kim, Y., Stolarska, M. & Othmer, H. The role of the microenvironment in tumor growth and invasion. Prog. Biophys. Mol. Biol. 106, 353\u2013379 (2011).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"647_CR99","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.annepidem.2018.11.010","volume":"30","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Does diabetes decrease the risk of glioma? A systematic review and meta-analysis of observational studies. Ann. Epidemiol. 30, 22\u201329 (2019).","journal-title":"Ann. Epidemiol."},{"key":"647_CR100","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.annepidem.2014.12.007","volume":"25","author":"B Krishnamachari","year":"2015","unstructured":"Krishnamachari, B. et al. A pooled multisite analysis of the effects of atopic medical conditions in glioma risk in different ethnic groups. Ann. Epidemiol. 25, 270\u2013274 (2015).","journal-title":"Ann. Epidemiol."},{"key":"647_CR101","doi-asserted-by":"publisher","first-page":"62598","DOI":"10.18632\/oncotarget.11545","volume":"7","author":"G Wang","year":"2016","unstructured":"Wang, G. et al. Evidence from a large-scale meta-analysis indicates eczema reduces the incidence of glioma. Oncotarget 7, 62598\u201362606 (2016).","journal-title":"Oncotarget"},{"key":"647_CR102","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/neuonc\/not070","volume":"15","author":"K Hemminki","year":"2013","unstructured":"Hemminki, K. et al. Subsequent brain tumors in patients with autoimmune disease. Neuro Oncol. 15, 1142\u20131150 (2013).","journal-title":"Neuro Oncol."},{"key":"647_CR103","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/cam4.2767","volume":"9","author":"T Anssar","year":"2020","unstructured":"Anssar, T. et al. Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma. Cancer Med. 9, 1263\u20131275 (2020).","journal-title":"Cancer Med."},{"key":"647_CR104","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41416-018-0009-x","volume":"118","author":"L Disney-Hogg","year":"2018","unstructured":"Disney-Hogg, L. et al. Influence of obesity-related risk factors in the aetiology of glioma. Br. J. Cancer 118, 1020\u20131027 (2018).","journal-title":"Br. J. Cancer"},{"key":"647_CR105","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.wneu.2017.06.164","volume":"106","author":"K Barami","year":"2017","unstructured":"Barami, K., Lyon, L. & Conell, C. Type 2 diabetes mellitus and glioblastoma multiforme-assessing risk and survival: results of a large retrospective study and systematic review of the literature. World Neurosurg. 106, 300\u2013307 (2017).","journal-title":"World Neurosurg."},{"key":"647_CR106","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41577-019-0131-x","volume":"19","author":"G Altan-Bonnet","year":"2019","unstructured":"Altan-Bonnet, G. & Mukherjee, R. Cytokine-mediated communication: a quantitative appraisal of immune complexity. Nat. Rev. Immunol. 19, 205\u2013217 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"647_CR107","doi-asserted-by":"publisher","first-page":"e102499","DOI":"10.1371\/journal.pone.0102499","volume":"9","author":"Y Kim","year":"2014","unstructured":"Kim, Y. et al. Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti-tumor efficacy: a mathematical model. PLoS ONE 9, e102499 (2014).","journal-title":"PLoS ONE"},{"key":"647_CR108","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-bioeng-110320-110749","volume":"24","author":"W Du","year":"2022","unstructured":"Du, W., Nair, P., Johnston, A., Wu, P. & Wirtz, D. Cell trafficking at the intersection of the tumor\u2013immune compartments. Annu. Rev. Biomed. Eng. 24, 275\u2013305 (2022).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"647_CR109","doi-asserted-by":"publisher","first-page":"110134","DOI":"10.1016\/j.isci.2024.110134","volume":"27","author":"P Brunner","year":"2024","unstructured":"Brunner, P., Kiwitz, L., Li, L. & Thurley, K. Diffusion-limited cytokine signaling in T cell populations. iScience 27, 110134 (2024).","journal-title":"iScience"},{"key":"647_CR110","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/cells13100844","volume":"13","author":"A Ryan","year":"2024","unstructured":"Ryan, A., Kim, M. & Lim, K. Immune cell migration to cancer. Cells 13, 844 (2024).","journal-title":"Cells"},{"key":"647_CR111","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jtbi.2005.12.022","volume":"241","author":"S McDougall","year":"2006","unstructured":"McDougall, S., Anderson, A. & Chaplain, M. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J. Theor. Biol. 241, 564\u2013589 (2006).","journal-title":"J. Theor. Biol."},{"key":"647_CR112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/cas.13395","volume":"109","author":"T Suzuki","year":"2018","unstructured":"Suzuki, T., Minerva, D., Nishiyama, K., Koshikawa, N. & Chaplain, M. Study on the tumor-induced angiogenesis using mathematical models. Cancer Sci. 109, 15\u201323 (2018).","journal-title":"Cancer Sci."},{"key":"647_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36707-6","volume":"14","author":"Y Ren","year":"2023","unstructured":"Ren, Y. et al. Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas. Nat. Commun. 14, 1028 (2023).","journal-title":"Nat. Commun."},{"key":"647_CR114","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2478\/raon-2024-0014","volume":"58","author":"H Ma","year":"2024","unstructured":"Ma, H. et al. Looking through the imaging perspective: the importance of imaging necrosis in glioma diagnosis and prognostic prediction\u2014single centre experience. Radio. Oncol. 58, 23\u201332 (2024).","journal-title":"Radio. Oncol."},{"key":"647_CR115","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s10147-025-02775-5","volume":"30","author":"Y Takido","year":"2025","unstructured":"Takido, Y. et al. Distant parenchymal recurrence during long-term use of ttfields treatment for glioblastoma. Int. J. Clin. Oncol. 30, 1309\u20131318 (2025).","journal-title":"Int. J. Clin. Oncol."},{"key":"647_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22697-9","volume":"8","author":"S Bette","year":"2018","unstructured":"Bette, S. et al. Retrospective analysis of radiological recurrence patterns in glioblastoma, their prognostic value and association to postoperative infarct volume. Sci. Rep. 8, 4561 (2018).","journal-title":"Sci. Rep."},{"key":"647_CR117","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu, D. et al. The blood\u2013brain barrier: structure, regulation, and drug delivery. Signal Transduct. Target Ther. 8, 217 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"647_CR118","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.apsb.2014.03.001","volume":"4","author":"X Wei","year":"2014","unstructured":"Wei, X., Chen, X., Ying, M. & Lu, W. Brain tumor-targeted drug delivery strategies. Acta Pharm. Sin. B 4, 193\u2013201 (2014).","journal-title":"Acta Pharm. Sin. B"},{"key":"647_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01610-7","volume":"20","author":"K Mitusova","year":"2022","unstructured":"Mitusova, K. et al. Overcoming the blood\u2013brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches. J. Nanobiotechnol. 20, 412 (2022).","journal-title":"J. Nanobiotechnol."},{"key":"647_CR120","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.274.5288.787","volume":"274","author":"DV Antwerp","year":"1996","unstructured":"Antwerp, D. V., Martin, S., Kafri, T., Green, D. & Verma, I. Suppression of tnf-alpha-induced apoptosis by nf-kappab. Science 274, 787\u2013789 (1996).","journal-title":"Science"},{"key":"647_CR121","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.bjc.6605530","volume":"102","author":"Y Wu","year":"2010","unstructured":"Wu, Y. & Zhou, B. Tnf-alpha\/nf-kappab\/snail pathway in cancer cell migration and invasion. Br. J. Cancer 102, 639\u2013644 (2010).","journal-title":"Br. J. Cancer"},{"key":"647_CR122","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41536-025-00414-1","volume":"10","author":"K Arkoudi","year":"2025","unstructured":"Arkoudi, K. et al. An nf-kb\/tnf-alpha signalling feedback loop acts to coordinate tissue regeneration and macrophage behaviour in zebrafish. NPJ Regen. Med. 10, 27 (2025).","journal-title":"NPJ Regen. Med."},{"key":"647_CR123","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00011-007-7220-1","volume":"57","author":"M Rasmussen","year":"2008","unstructured":"Rasmussen, M. et al. Il-8 and p53 are inversely regulated through jnk, p38 and nf-kappab p65 in hepg2 cells during an inflammatory response. Inflamm. Res. 57, 329\u2013339 (2008).","journal-title":"Inflamm. Res."},{"key":"647_CR124","doi-asserted-by":"publisher","first-page":"e73409","DOI":"10.1371\/journal.pone.0073409","volume":"8","author":"D De","year":"2013","unstructured":"De, D., Datta, A., Bhattacharjya, S. & Roychoudhury, S. Nf-kappab mediated transcriptional repression of acid modifying hormone gastrin. PLoS ONE 8, e73409 (2013).","journal-title":"PLoS ONE"},{"key":"647_CR125","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1172\/JCI11837","volume":"107","author":"G Zhang","year":"2001","unstructured":"Zhang, G. & Ghosh, S. Toll-like receptor-mediated nf-kappab activation: a phylogenetically conserved paradigm in innate immunity. J. Clin. Investig. 107, 13\u201319 (2001).","journal-title":"J. Clin. Investig."},{"key":"647_CR126","doi-asserted-by":"publisher","first-page":"108926","DOI":"10.1016\/j.abb.2021.108926","volume":"706","author":"C Park","year":"2021","unstructured":"Park, C., Cha, H., Lee, H., Kim, G. & Choi, Y. The regulation of the tlr4\/nf-kb and nrf2\/ho-1 signaling pathways is involved in the inhibition of lipopolysaccharide-induced inflammation and oxidative reactions by morroniside in raw 264.7 macrophages. Arch. Biochem. Biophys. 706, 108926 (2021).","journal-title":"Arch. Biochem. Biophys."},{"key":"647_CR127","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1172\/JCI26322","volume":"115","author":"J Luo","year":"2005","unstructured":"Luo, J., Kamata, H. & Karin, M. Ikk\/nf-kappab signaling: balancing life and death\u2014a new approach to cancer therapy. J. Clin. Investig. 115, 2625\u20132632 (2005).","journal-title":"J. Clin. Investig."},{"key":"647_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2399-y","volume":"11","author":"D Verzella","year":"2020","unstructured":"Verzella, D. et al. Life, death, and autophagy in cancer: Nf-kb turns up everywhere. Cell Death Dis. 11, 210 (2020).","journal-title":"Cell Death Dis."},{"key":"647_CR129","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/ni.1899","volume":"11","author":"K Murphy","year":"2010","unstructured":"Murphy, K. & Stockinger, B. Effector t cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 11, 674\u2013680 (2010).","journal-title":"Nat. Immunol."},{"key":"647_CR130","doi-asserted-by":"publisher","first-page":"e002555","DOI":"10.1136\/jitc-2021-002555","volume":"9","author":"D Tantalo","year":"2021","unstructured":"Tantalo, D. et al. Understanding t cell phenotype for the design of effective chimeric antigen receptor t cell therapies. J. Immunother. Cancer 9, e002555 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"647_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.898","volume":"12","author":"M Barberis","year":"2022","unstructured":"Barberis, M. & Lopez, A. T cell phenotype switching in autoimmune disorders: clinical significance of targeting metabolism. Clin. Transl. Med. 12, e898 (2022).","journal-title":"Clin. Transl. Med."},{"key":"647_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02632-1","volume":"18","author":"M Khan","year":"2020","unstructured":"Khan, M. Regulatory t cells mediated immunomodulation during asthma: a therapeutic standpoint. J. Transl. Med. 18, 456 (2020).","journal-title":"J. Transl. Med."},{"key":"647_CR133","doi-asserted-by":"publisher","first-page":"32977","DOI":"10.18632\/oncotarget.16516","volume":"8","author":"Y Pan","year":"2017","unstructured":"Pan, Y., Smithson, L., Ma, Y., Hambardzumyan, D. & Gutmann, D. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival. Oncotarget 8, 32977\u201332989 (2017).","journal-title":"Oncotarget"},{"key":"647_CR134","doi-asserted-by":"publisher","first-page":"115114","DOI":"10.1016\/j.expneurol.2024.115114","volume":"385","author":"Y An","year":"2025","unstructured":"An, Y. et al. The role of the ccl5\u2013ccr5 axis in microglial activation leading to postoperative cognitive dysfunction. Exp. Neurol. 385, 115114 (2025).","journal-title":"Exp. Neurol."},{"key":"647_CR135","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.3390\/ijms21197348","volume":"21","author":"H Yeo","year":"2020","unstructured":"Yeo, H., Lee, Y., Koh, D., Lim, Y. & Shin, S. Chrysin inhibits nf-\u03bab-dependent ccl5 transcription by targeting i\u03bab kinase in the atopic dermatitis-like inflammatory microenvironment. Int. J. Mol. Sci. 21, 7348 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"647_CR136","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1038\/emboj.2010.256","volume":"29","author":"M Ren","year":"2010","unstructured":"Ren, M. et al. Polymerization of mip-1 chemokine (ccl3 and ccl4) and clearance of mip-1 by insulin-degrading enzyme. EMBO J. 29, 3952\u20133966 (2010).","journal-title":"EMBO J."},{"key":"647_CR137","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.jmb.2015.01.012","volume":"427","author":"W Liang","year":"2015","unstructured":"Liang, W., Ren, M., Zhao, F. & Tang, W. Structures of human ccl18, ccl3, and ccl4 reveal molecular determinants for quaternary structures and sensitivity to insulin-degrading enzyme. J. Mol. Biol. 427, 1345\u20131358 (2015).","journal-title":"J. Mol. Biol."},{"key":"647_CR138","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1182\/blood-2013-06-510875","volume":"123","author":"L Weckbach","year":"2014","unstructured":"Weckbach, L. et al. The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via \u03b22 integrins (cd11\/cd18). Blood 123, 1887\u20131896 (2014).","journal-title":"Blood"},{"key":"647_CR139","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1124\/mol.104.008565","volume":"67","author":"C Watson","year":"2005","unstructured":"Watson, C., Jenkinson, S., Kazmierski, W. & Kenakin, T. The ccr5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive hiv entry inhibitor. Mol. Pharm. 67, 1268\u20131282 (2005).","journal-title":"Mol. Pharm."},{"key":"647_CR140","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1074\/jbc.M110.168955","volume":"286","author":"J Garcia-Perez","year":"2011","unstructured":"Garcia-Perez, J. et al. New insights into the mechanisms whereby low molecular weight ccr5 ligands inhibit hiv-1 infection. J. Biol. Chem. 286, 4978\u20134990 (2011).","journal-title":"J. Biol. Chem."},{"key":"647_CR141","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1111\/bph.12683","volume":"171","author":"D Swinney","year":"2014","unstructured":"Swinney, D. et al. A study of the molecular mechanism of binding kinetics and long residence times of human ccr5 receptor small molecule allosteric ligands. Br. J. Pharm. 171, 3364\u20133375 (2014).","journal-title":"Br. J. Pharm."},{"key":"647_CR142","doi-asserted-by":"publisher","first-page":"21415","DOI":"10.1074\/jbc.M210977200","volume":"278","author":"M Jonsson","year":"2003","unstructured":"Jonsson, M., Eklund, E., Fransson, L. & Oldberg, A. Initiation of the decorin glycosaminoglycan chain in the endoplasmic reticulum-golgi intermediate compartment. J. Biol. Chem. 278, 21415\u201321420 (2003).","journal-title":"J. Biol. Chem."},{"key":"647_CR143","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1110\/ps.037481.108","volume":"17","author":"S Bergqvist","year":"2008","unstructured":"Bergqvist, S., Ghosh, G. & Komives, E. A. The IkBa\/NF-kB complex has two hot spots, one at either end of the interface. Protein Sci. 17, 2051\u20132058 (2008).","journal-title":"Protein Sci."},{"key":"647_CR144","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/emboj.2008.73","volume":"27","author":"E Mathes","year":"2008","unstructured":"Mathes, E., O\u2019Dea, E. L., Hoffmann, A. & Ghosh, G. NF-kB dictates the degradation pathway of IkBa. EMBO J. 27, 1357\u20131367 (2008).","journal-title":"EMBO J."},{"key":"647_CR145","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jtbi.2004.01.001","volume":"228","author":"T Lipniacki","year":"2004","unstructured":"Lipniacki, T., Paszek, P., Brasier, A., Luxon, B. & Kimmel, M. Mathematical model of nf-kappab regulatory module. J. Theor. Biol. 228, 195\u2013215 (2004).","journal-title":"J. Theor. Biol."},{"key":"647_CR146","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1126\/science.289.5488.2350","volume":"289","author":"E Lee","year":"2000","unstructured":"Lee, E. et al. Failure to regulate tnf-induced nf-kappab and cell death responses in a 20-deficient mice. Science 289, 2350\u20134 (2000).","journal-title":"Science"},{"key":"647_CR147","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/bies.201400113","volume":"37","author":"J Mothes","year":"2015","unstructured":"Mothes, J., Busse, D., Kofahl, B. & Wolf, J. Sources of dynamic variability in nf-kb signal transduction: a mechanistic model. Bioessays 37, 452\u201362 (2015).","journal-title":"Bioessays"},{"key":"647_CR148","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.biosystems.2013.09.001","volume":"114","author":"X Xue","year":"2013","unstructured":"Xue, X., Xia, W. & Wenzhong, H. A modeled dynamic regulatory network of nf-\u03bab and il-6 mediated by mirna. Biosystems 114, 214\u20138 (2013).","journal-title":"Biosystems"},{"key":"647_CR149","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/sj.onc.1210683","volume":"27","author":"A Wesolowska","year":"2008","unstructured":"Wesolowska, A. et al. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion\u2013an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type ii receptor. Oncogene 27, 918\u201330 (2008).","journal-title":"Oncogene"},{"key":"647_CR150","first-page":"519","volume":"64","author":"Y Kim","year":"2017","unstructured":"Kim, Y., Jeon, H. & Othmer, H. The role of the tumor microenvironment in glioblastoma: a mathematical model. IEEE Trans. Biomed. Eng. 64, 519\u2013527 (2017).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"647_CR151","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.4049\/jimmunol.170.10.4963","volume":"170","author":"E Deenick","year":"2003","unstructured":"Deenick, E., Gett, A. & Hodgkin, P. Stochastic model of t cell proliferation: a calculus revealing il-2 regulation of precursor frequencies, cell cycle time, and survival. J. Immunol. 170, 4963\u20134972 (2003).","journal-title":"J. Immunol."},{"key":"647_CR152","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/79782","volume":"1","author":"A Gett","year":"2000","unstructured":"Gett, A. & Hodgkin, P. A cellular calculus for signal integration by t cells. Nat. Immunol. 1, 239\u2013244 (2000).","journal-title":"Nat. Immunol."},{"key":"647_CR153","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.4049\/jimmunol.162.9.5212","volume":"162","author":"H Gudmundsdottir","year":"1999","unstructured":"Gudmundsdottir, H., Wells, A. & Turka, L. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J. Immunol. 162, 5212\u20135223 (1999).","journal-title":"J. Immunol."},{"key":"647_CR154","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1440-1711.2006.01425.x","volume":"84","author":"A Jansson","year":"2006","unstructured":"Jansson, A., Fagerlind, M., Karlsson, D., Nilsson, P. & Cooley, M. In silico simulations suggest that Th-cell development is regulated by both selective and instructive mechanisms. Immunol. Cell Biol. 84, 218\u2013226 (2006).","journal-title":"Immunol. Cell Biol."},{"key":"647_CR155","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.4049\/jimmunol.178.8.5375","volume":"178","author":"Y Kim","year":"2007","unstructured":"Kim, Y. et al. Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J. Immunol. 178, 5375\u20135382 (2007).","journal-title":"J. Immunol."},{"key":"647_CR156","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3934\/mbe.2013.10.1095","volume":"10","author":"Y Kim","year":"2013","unstructured":"Kim, Y. et al. Regulation of Th1\/Th2 cells in asthma development: a mathematical model. Math. Bios. Eng. 10, 1095\u20131133 (2013).","journal-title":"Math. Bios. Eng."},{"key":"647_CR157","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2739\/kurumemedj.MS6430001","volume":"64","author":"T Kawayama","year":"2018","unstructured":"Kawayama, T. et al. Role of regulatory T cells in airway inflammation in asthma. Kurum. Med. J. 64, 45\u201355 (2018).","journal-title":"Kurum. Med. J."},{"key":"647_CR158","doi-asserted-by":"publisher","first-page":"e20221094","DOI":"10.1084\/jem.20221094","volume":"220","author":"J Harker","year":"2023","unstructured":"Harker, J. & Lloyd, C. T helper 2 cells in asthma. J. Exp. Med. 220, e20221094 (2023).","journal-title":"J. Exp. Med."},{"key":"647_CR159","first-page":"4853","volume":"17","author":"H Qiao","year":"2018","unstructured":"Qiao, H. et al. The effects of interleukin 2 and rad-p53 as a treatment for glioblastoma. Mol. Med. Rep. 17, 4853\u20134859 (2018).","journal-title":"Mol. Med. Rep."},{"key":"647_CR160","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"S Ross","year":"2018","unstructured":"Ross, S. & Cantrell, D. Signaling and function of interleukin-2 in T lymphocytes. Annu. Rev. Immunol. 36, 411\u2013433 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"647_CR161","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4049\/jimmunol.134.1.157","volume":"134","author":"M Lotze","year":"1985","unstructured":"Lotze, M., Frana, L., Sharrow, S., Robb, R. & Rosenberg, S. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the jurkat cell line-derived interleukin 2. J. Immunol. 134, 157\u2013166 (1985).","journal-title":"J. Immunol."},{"key":"647_CR162","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1023\/A:1008362620308","volume":"10","author":"P Schiphorst","year":"1999","unstructured":"Schiphorst, P., Chang, P., Clar, N., Schoemaker, R. & Osanto, S. Pharmacokinetics of interleukin-2 in two anephric patients with metastatic renal cell cancer. Ann. Oncol. 10, 1381\u20131383 (1999).","journal-title":"Ann. Oncol."},{"key":"647_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87102-4","volume":"11","author":"A Ottolenghi","year":"2021","unstructured":"Ottolenghi, A. et al. Life-extended glycosylated il-2 promotes treg induction and suppression of autoimmunity. Sci. Rep. 11, 7676 (2021).","journal-title":"Sci. Rep."},{"key":"647_CR164","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1440-1711.2005.01345.x","volume":"83","author":"P Hillyer","year":"2005","unstructured":"Hillyer, P. & Male, D. Expression of chemokines on the surface of different human endothelia. Immunol. Cell Biol. 83, 375\u2013382 (2005).","journal-title":"Immunol. Cell Biol."},{"key":"647_CR165","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1073\/pnas.1715295115","volume":"115","author":"Y Kim","year":"2018","unstructured":"Kim, Y. et al. Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy. Proc. Natl. Acad. Sci. USA 115, 4927\u20134932 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"647_CR166","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1158\/0008-5472.CAN-05-2661","volume":"66","author":"A Friedman","year":"2006","unstructured":"Friedman, A., Tian, J., Fulci, G., Chiocca, E. & Wang, J. Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity. Cancer Res. 66, 2314\u20139 (2006).","journal-title":"Cancer Res."},{"key":"647_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03425-8","volume":"23","author":"F Zhao","year":"2025","unstructured":"Zhao, F. et al. Co-encapsulation of norcantharidin prodrugs and lomitapide in nanoparticles to regulate ccl4 expression by inhibiting wnt\/\u03b2-catenin pathway for improved anti-tumor immunotherapy. J. Nanobiotechnol. 23, 369 (2025).","journal-title":"J. Nanobiotechnol."},{"key":"647_CR168","doi-asserted-by":"crossref","unstructured":"Bisswanger, H. Enzyme Kinetics: Principles and Methods, 3rd, enlarged and improved edn (Wiley-VCH, 2017).","DOI":"10.1002\/9783527806461"},{"key":"647_CR169","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1128\/JVI.73.1.205-213.1999","volume":"73","author":"A Albright","year":"1999","unstructured":"Albright, A. et al. Microglia express ccr5, cxcr4, and ccr3, but of these, ccr5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J. Virol. 73, 205\u2013213 (1999).","journal-title":"J. Virol."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00647-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00647-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00647-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:04:10Z","timestamp":1770901450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00647-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":169,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1038\/s41540-026-00647-w","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}